Agilent Technologies (A) Liabilities and Shareholders Equity (2009 - 2026)
Agilent Technologies' (A) quarterly Liabilities and Shareholders Equity came in at $14.0 billion in Q3 2026, up 14.24% year-over-year from $12.2 billion in Q3 2025, and up 6.9% quarter-over-quarter from $13.1 billion in Q2 2026.
Analysis
Agilent Technologies (A) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $14.0 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 14.24% year-over-year to $14.0 billion in Q3 2026; TTM through Jul 2026 was $52.6 billion, a 9.2% increase from a year earlier, with the FY2025 full-year figure at $12.7 billion, up 7.44% from the prior year.
- Liabilities and Shareholders Equity was $14.0 billion for Q3 2026 at Agilent Technologies, up from $13.1 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $14.0 billion in Q3 2026 and troughed at $10.3 billion in Q1 2022.
- A 5-year average of $11.5 billion and a median of $10.9 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity dropped 1.62% in 2022 and gained 14.24% in 2026, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $10.5 billion in 2022, then climbed by 2.19% to $10.8 billion in 2023, then advanced by 10.06% to $11.8 billion in 2024, then gained by 7.44% to $12.7 billion in 2025, then climbed by 9.74% to $14.0 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $14.0 billion (Q3 2026), $13.1 billion (Q2 2026), and $12.8 billion (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 13.97 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 6.65 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 12.05 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 2.59 Bn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 10.25 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 2.95 Bn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 1.03 Bn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 6.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 13.97 Bn |
| Apr 30, 2026 | 13.07 Bn |
| Jan 31, 2026 | 12.81 Bn |
| Oct 31, 2025 | 12.73 Bn |
| Jul 31, 2025 | 12.23 Bn |
| Apr 30, 2025 | 12.16 Bn |
| Jan 31, 2025 | 11.91 Bn |
| Oct 31, 2024 | 11.85 Bn |
| Jul 31, 2024 | 11.00 Bn |
| Apr 30, 2024 | 10.86 Bn |
| Jan 31, 2024 | 10.95 Bn |
| Oct 31, 2023 | 10.76 Bn |
| Jul 31, 2023 | 10.68 Bn |
| Apr 30, 2023 | 10.79 Bn |
| Jan 31, 2023 | 10.92 Bn |
| Oct 31, 2022 | 10.53 Bn |
| Jul 31, 2022 | 10.48 Bn |
| Apr 30, 2022 | 10.46 Bn |
| Jan 31, 2022 | 10.33 Bn |
| Oct 31, 2021 | 10.71 Bn |